Suggested Topics within your search.
Suggested Topics within your search.
- methods 5
- Therapeutic use 4
- therapeutic use 4
- Anesthesia 3
- Anesthetics 3
- therapy 3
- Anesthesiology 2
- Biochemistry 2
- Chemistry, Clinical 2
- Chemotherapy 2
- Cognitive Therapy 2
- Health and Fitness 2
- Pharmacology 2
- pharmacology 2
- Analgesia 1
- Analgesics 1
- Anti-Infective Agents 1
- Anti-infective agents 1
- Anxiety Disorders 1
- Child welfare 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Cognitive therapy 1
- Communicable diseases in children 1
- Congresses 1
- Cultural Diversity 1
- Custody of children 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
-
12341
Analysis of geothermal impact on metabolite compounds of heat-tolerant plant species using clustering and similarity cliff
Published 2024-10-01“…These areas are also known to harbor a variety of medicinal plants, historically used for therapeutic properties. Nevertheless, there is a scarcity of information concerning the precise chemical compounds present in plants originating from geothermal regions, especially in relation to their diversity and potential medicinal uses. …”
Get full text
Article -
12342
Exploring the role of inflammatory biomarkers in trigeminal neuralgia
Published 2025-02-01“…SCGF-β and IL-4 are potential therapeutic targets due to their facilitative effects on TN, while IL-16 could offer protective benefits. …”
Get full text
Article -
12343
Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study
Published 2025-01-01“…HOMA-IR and glucagon kinetics did not change with the addition of imeglimin.Conclusion: The addition of imeglimin to DPP-4i significantly improved glycemic control and glycemic variability, based on increased glucose-induced insulin secretion, indicating its potential as a therapeutic option for patients with T2D.Keywords: imeglimin, DPP-4 inhibitor, time in range, glycemic variability, continuous glucose monitoring, meal tolerance test…”
Get full text
Article -
12344
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized,...
Published 2025-01-01“…On the molecular level, TSC is caused by heterozygous loss-of-function variants in either of the genes TSC1 or TSC2, encoding the Tuberin-Hamartin complex, which acts as a critical upstream suppressor of the mammalian target of rapamycin (mTOR), a key signaling pathway controlling cellular growth and metabolism. Despite the therapeutic success of mTOR inhibition in treating TSC-associated manifestations, studies with mTOR inhibitors in children with TSC above two years of age have failed to demonstrate beneficial effects on disease-related neuropsychological deficits. …”
Get full text
Article -
12345
Identification of cancer cell-intrinsic biomarkers associated with tumor progression and characterization of SFTA3 as a tumor suppressor in lung adenocarcinomas
Published 2025-01-01“…Abstract Background Recent advancements in contemporary therapeutic approaches have increased the survival rates of lung cancer patients; however, the long-term benefits remain constrained, underscoring the pressing need for novel biomarkers. …”
Get full text
Article -
12346
Investigation of gut microbiota in pediatric patients with peanut allergy in outpatient settings
Published 2025-02-01“…These results suggest that modulating the gut microbiota may be a viable therapeutic strategy for managing peanut allergy and highlight the need for further research to explore the clinical implications of these microbial changes.…”
Get full text
Article -
12347
Biosynthesis, characterization, and in-vitro anticancer effect of plant-mediated silver nanoparticles using Acalypha indica Linn: In-silico approach
Published 2025-01-01“…(AgNPs), a medicinal plant recognized for its therapeutic benefits, as a potential cancer treatment with minimal side effects and a lower risk of drug resistance. …”
Get full text
Article -
12348
A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome
Published 2025-02-01“…The production of this bacteriocin by a gut-derived S. salivarius, its narrow-spectrum activity, and its anti-F. nucleatum activity in a model colonic environment indicates that this strain merits further attention with a view to harnessing its probiotic potential.IMPORTANCEFusobacterium nucleatum is a human pathogen associated with intestinal conditions, including colorectal cancer, making it a potentially important therapeutic target. Bacteriocin-producing probiotic bacteria demonstrate the potential to target disease-associated taxa in situ in the gut. …”
Get full text
Article -
12349
Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation
Published 2025-01-01“…This study provides new insight into the potential mechanism of RosA in treating LUAD and provides a new therapeutic avenue for treatment of LUAD.…”
Get full text
Article -
12350
Consumption of Raw Herbal Medicines Is Associated with Major Public Health Risks amongst Ugandans
Published 2023“…In Uganda, Vernonia amygdalina is of interest in rural communities due to its therapeutical action on both bacterial and protozoal parasites, however no studies have been conducted to assess the heavy metal concentrations in traditional plants used in alternative medicine. …”
Get full text
Article -
12351
CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4–TGFα–EGFR signaling
Published 2025-01-01“…Conclusions CircUCK2(2,3) regulates a novel oncogenic pathway, miR-149-5p–CNIH4–TGFα–EGFR, in HCC, presenting a viable therapeutic target and biomarker for the precision treatment of HCC. …”
Get full text
Article -
12352
Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord–Derived Mesenchymal Stem Cell–Mediated Rheumatoid Arthritis Therapy
Published 2025-01-01“…Inspired by these findings, we aimed to evaluate whether TNFR1 determine the therapeutic effects of hUC-MSCs on RA. First, we investigated whether TNFR1 is necessary for hUC-MSCs to inhibit TNF-α production of PBMCs, a source of elevated TNF-α in patients. …”
Get full text
Article -
12353
Wu-Mei-Wan enhances brown adipose tissue function and white adipose browning in obese mice via upregulation of HSF1
Published 2025-01-01“…Conclusions WMW represents a potent therapeutic strategy for obesity, promoting metabolic health and beneficial modulation of adipose tissue through an HSF1-dependent pathway.…”
Get full text
Article -
12354
Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR/PI3K/AKT/GPX4 signalling axis
Published 2025-01-01“…This study suggests that ORes holds promise as a potential therapeutic agent for breast cancer and warrants further investigation into its clinical applications and potential integration into existing treatment regimens.…”
Get full text
Article -
12355
Multidrug-resistant ST11-KL64 hypervirulent Klebsiella pneumoniae with multiple bla- genes isolated from children's blood
Published 2025-01-01“…The findings highlight the urgent need for effective surveillance, infection control measures, and novel therapeutic strategies to manage such hypervirulent and multidrug-resistant pathogens.…”
Get full text
Article -
12356
N1-methylnicotinamide promotes age-related cochlear damage via the overexpression of SIRT1
Published 2025-01-01“…The dual role of SIRT1 emphasizes the need for precise modulation of its expression for effective therapeutic interventions. Future research should explore mechanisms underlying SIRT1-induced cochlear damage and strategies to maintain balanced SIRT1 expression. …”
Get full text
Article -
12357
Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound Healing
Published 2020-01-01“…The GLP-2 receptor (GLP-2R) is expressed in the stroma of the large bowel wall, which is the major therapeutic target area to prevent anastomotic leakage. …”
Get full text
Article -
12358
Protocol for a multicentre, prospective, open-label, randomised controlled trial to compare PROs and safety outcomes between preoperative and postmastectomy radiotherapy in locally...
Published 2025-01-01“…Introduction Despite its therapeutic advantages, postmastectomy radiotherapy (PMRT) increases the risk of complications and often leads to poor cosmesis in women undergoing breast reconstruction. …”
Get full text
Article -
12359
Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines
Published 2025-01-01“…Also, pretreatment of TGM2high PDOs with sublethal doses of the spindle poisons paclitaxel or vincristine increased CD8+T cell activation and sensitized PDOs toward T cell-mediated cytotoxicity.Conclusions These findings indicate that targeting microtubular function therapeutically may enhance antitumor T cell responses by impacting activity of immunosuppressive cytokines in the PDAC microenvironment.…”
Get full text
Article -
12360
Antithrombotic therapy for a case report of acute myocardial infarction after laparoscopic radical cystectomy
Published 2025-01-01“…BackgroundRadical cystectomy constitutes the standard therapeutic approach for high-risk urothelial carcinomas of the bladder. …”
Get full text
Article